SARS-CoV-2 isolated from a human oro-nasal combined swab. Omicron BA.2, Pango Lineage B.1.1.529.2.9. Passage 3 grown in hSLAM cells. Sequencing performed after purchase.
SARS-CoV-2 isolated from a human oro-nasal combined swab. Omicron BA.2, pango lineage B.1.1.529.2. Passage 3 grown in hSLAM cells. Sequencing performed after purchase.
SARS-CoV-2 isolated from a human oro-nasal combined swab. Omicron BA.2, Pango Lineage B.1.1.529. Passage 3 grown in hSLAM cells. Sequencing performed after purchase.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P4-GII.4/NV-22-001. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-002. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-003. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-005. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.2/NV-22-006. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P4-GII.4/NV-22-007. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P7-GII.6/NV-22-008. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-009. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-010. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-099. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-001. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-002. Material 10-20% fecal material in virus culture medium.